Hartmut Ehrlich: CEO of Abivax

BioBoss

English - April 22, 2023 16:00 - 50 minutes - 34.5 MB - ★★★★★ - 7 ratings
Life Sciences Science Business Investing biopharma pharmaceutical biotech leadership ceo founder biopharmaceuticals innovation interview Homepage Download Apple Podcasts Google Podcasts Overcast Castro Pocket Casts RSS feed

Previous Episode: #58 - Ivo Timmermans: co-founder & CEO, Pleco Therapeutics

Next Episode: #60 - Naseem Amin: CEO of Orphalan

Hartmut Ehrlich, CEO of Abivax, shares his thoughts with BioBoss host John Simboli about leadership in biopharma and how Abivax is working to develop treatments modulating the body’s natural immune system to treat patients with chronic inflammatory diseases, viral infections and cancer.